ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ABL2 |
P42684
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
Kinase
|
3.6E-07 |
0.619 |
0.654 |
AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ALOX5 |
P09917
|
arachidonate 5-lipoxygenase
|
Enzyme
|
1.2E-06 |
0.447 |
0.885 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
ARR3 |
P36575
|
arrestin 3
|
Enzyme modulator
|
0.10 |
0.460 |
0.846 |
ATF2 |
P15336
|
activating transcription factor 2
|
Transcription factor
|
0.99 |
0.551 |
0.808 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BBC3 |
Q96PG8 Q9BXH1
|
BCL2 binding component 3
|
|
4.0E-03 |
0.517 |
0.769 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
BCL2L2 |
Q92843
|
BCL2 like 2
|
Signaling
|
0.47 |
0.599 |
0.615 |
BCL2L2-PABPN1 |
Q92843
|
BCL2L2-PABPN1 readthrough
|
|
0.28 |
0.653 |
0.500 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BMS1P20 |
|
BMS1 pseudogene 20
|
|
|
0.682 |
0.577 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
BTK |
Q06187
|
Bruton tyrosine kinase
|
Kinase
|
1.00 |
0.464 |
0.808 |